BioCryst Pharmaceuticals Announces Appointment Of Thomas Staab As Its Next Chief Financial Officer

Inc. in 2003. Before joining Triangle, Mr. Staab spent eight years working for PricewaterhouseCoopers LLP providing audit and business advisory services to national and multi-national corporations in the biotechnology, pharmaceutical, pulp and paper and...